Newborn Screening (NBS)
Newborn Screening for Cystic Fibrosis in California
13
Newborn Screening for Pompe Disease
12
Reflections on 50 Years of Newborn Screening
5
Newborn screening in mucopolysaccharidoses
10
Newborn Screening Technology: Proceed With Caution
9
State Laws Regarding the Retention and Use of Residual Newborn Screening Blood Samples
12
We Need Expanded Newborn Screening
8
Newborn Screening for Biliary Atresia
9
Examination of the Communication Practices Between State Newborn Screening Programs and the Medical Home
9
Newborn Screening Fact Sheets
32
A Vision of the Future of Newborn Screening
7
Status of Newborn Screening Programs in the United States
43
Introduction to the Newborn Screening Fact Sheets
11
American Academy of Pediatrics Newborn Screening Task Force Recommendations: How Far Have We Come?
20
Comprehensive Cost-Utility Analysis of Newborn Screening Strategies
11
Parents' Experiences of Expanded Newborn Screening Evaluations
11
Newborn Screening for Duchenne Muscular Dystrophy
7
Newborn Screening: A Blueprint for the Future Executive Summary: Newborn Screening Task Force Report
5
Preferences for aspects of antenatal and newborn screening: a systematic review
11
Legal and Ethical Issues in Newborn Screening
5